Welcome to our investor pages

Medical technology company Optomed is leading producer of handheld fundus cameras globally.

  • Net sales 13,0 EUR, million
  • Gross margin 68.8  %
  • Adjusted EBITDA -0.7 EUR, million
  • Equity ratio 64.6 %
Key figures

Share Price
Nasdaq Helsinki Stock Exchange

Doctor taking fundus image of a girls eye with Optomed Aurora IQ

Optomed Plc’s Half-year report, January – June 2021

Read more

Latest releases

Next IR events

Nov 4 - Nov 4, 2021

Optomed will publish Q3-2021 Interim Report

Nov 11 - Nov 11, 2021

Redeye Life Science Day

Feb 17 - Feb 17, 2022

Optomed Plc will release its Financial Statement Bulletin for 1 January – 31 December 2021

May 5 - May 5, 2022

Optomed Plc will release its Interim Report for 1 January – 31 March 2021

Aug 4 - Aug 4, 2022

Optomed Plc will release its Half-Year Financial Report for 1 January – 30 June 2022

Nov 3 - Nov 3, 2022

Optomed Plc will release its Interim Report for 1 January – 30 September 2022

Optomed as an investment

Optomed is a research and development as well as sales driven medical technology company in expansion phase.

Optomed is one of the leading players in the growing and transforming handheld fundus camera market.

Read more